Article Test

Colorectal cancer remains the third most common cancer worldwide and ranks 2^nd in cancer-related mortality in developed countries. The liver is the first organ involved with metastatic disease after lymph node spread is excluded. Colorectal liver metastases (CRLM) are present in over 70% of patients dying from disseminated colorectal cancer. The approach to investigation and management of CRLM remains a complex area, in which practice is continuing to evolve with new evidence, and which ongoing research is ongoing. This review aims to provide a broad, up-to-date overview of the current landscape of the literature in regards to imaging modalities used in diagnosis and staging of CRLM, the multiple surgical management options available, as well as the adjunct therapies and chemotherapy regimens utilised.